Literature DB >> 27545675

Variants in HNRNPH2 on the X Chromosome Are Associated with a Neurodevelopmental Disorder in Females.

Jennifer M Bain1, Megan T Cho2, Aida Telegrafi2, Ashley Wilson3, Susan Brooks4, Christina Botti4, Gordon Gowans5, Leigh Anne Autullo5, Vidya Krishnamurthy6, Marcia C Willing7, Tomi L Toler7, Bruria Ben-Zev8, Orly Elpeleg9, Yufeng Shen10, Kyle Retterer2, Kristin G Monaghan2, Wendy K Chung11.   

Abstract

Via whole-exome sequencing, we identified six females from independent families with a common neurodevelopmental phenotype including developmental delay, intellectual disability, autism, hypotonia, and seizures, all with de novo predicted deleterious variants in the nuclear localization signal of Heterogeneous Nuclear Ribonucleoprotein H2, encoded by HNRNPH2, a gene located on the X chromosome. Many of the females also have seizures, psychiatric co-morbidities, and orthopedic, gastrointestinal, and growth problems as well as common dysmorphic facial features. HNRNPs are a large group of ubiquitous proteins that associate with pre-mRNAs in eukaryotic cells to produce a multitude of alternatively spliced mRNA products during development and play an important role in controlling gene expression. The failure to identify affected males, the severity of the neurodevelopmental phenotype in females, and the essential role of this gene suggests that male conceptuses with these variants may not be viable.
Copyright © 2016 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HNRNPH2; X chromosome; alternative splicing; autism; developmental delay; microcephaly; neurodevelopment; pre-mRNA

Mesh:

Substances:

Year:  2016        PMID: 27545675      PMCID: PMC5011042          DOI: 10.1016/j.ajhg.2016.06.028

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

Review 1.  Genetics of intellectual disability.

Authors:  H Hilger Ropers
Journal:  Curr Opin Genet Dev       Date:  2008-08-28       Impact factor: 5.578

Review 2.  Molecular mechanisms of fragile X syndrome: a twenty-year perspective.

Authors:  Michael R Santoro; Steven M Bray; Stephen T Warren
Journal:  Annu Rev Pathol       Date:  2011-10-10       Impact factor: 23.472

3.  De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies.

Authors:  Jason Homsy; Samir Zaidi; Yufeng Shen; James S Ware; Kaitlin E Samocha; Konrad J Karczewski; Steven R DePalma; David McKean; Hiroko Wakimoto; Josh Gorham; Sheng Chih Jin; John Deanfield; Alessandro Giardini; George A Porter; Richard Kim; Kaya Bilguvar; Francesc López-Giráldez; Irina Tikhonova; Shrikant Mane; Angela Romano-Adesman; Hongjian Qi; Badri Vardarajan; Lijiang Ma; Mark Daly; Amy E Roberts; Mark W Russell; Seema Mital; Jane W Newburger; J William Gaynor; Roger E Breitbart; Ivan Iossifov; Michael Ronemus; Stephan J Sanders; Jonathan R Kaltman; Jonathan G Seidman; Martina Brueckner; Bruce D Gelb; Elizabeth Goldmuntz; Richard P Lifton; Christine E Seidman; Wendy K Chung
Journal:  Science       Date:  2015-12-04       Impact factor: 47.728

Review 4.  X-linked mental deficiency.

Authors:  Vincent des Portes
Journal:  Handb Clin Neurol       Date:  2013

5.  A glycine-rich domain of hnRNP H/F promotes nucleocytoplasmic shuttling and nuclear import through an interaction with transportin 1.

Authors:  Courtney M Van Dusen; Lily Yee; Lisa M McNally; Mark T McNally
Journal:  Mol Cell Biol       Date:  2010-03-22       Impact factor: 4.272

6.  Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.

Authors:  J F Cáceres; S Stamm; D M Helfman; A R Krainer
Journal:  Science       Date:  1994-09-16       Impact factor: 47.728

7.  Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome.

Authors:  Peng Jin; Ranhui Duan; Abrar Qurashi; Yunlong Qin; Donghua Tian; Tracie C Rosser; Huijie Liu; Yue Feng; Stephen T Warren
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

8.  FUS-NLS/Transportin 1 complex structure provides insights into the nuclear targeting mechanism of FUS and the implications in ALS.

Authors:  Chunyan Niu; Jiayu Zhang; Feng Gao; Liuqing Yang; Minze Jia; Haining Zhu; Weimin Gong
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

9.  ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function.

Authors:  Tetsuro Murakami; Seema Qamar; Julie Qiaojin Lin; Gabriele S Kaminski Schierle; Eric Rees; Akinori Miyashita; Ana R Costa; Roger B Dodd; Fiona T S Chan; Claire H Michel; Deborah Kronenberg-Versteeg; Yi Li; Seung-Pil Yang; Yosuke Wakutani; William Meadows; Rodylyn Rose Ferry; Liang Dong; Gian Gaetano Tartaglia; Giorgio Favrin; Wen-Lang Lin; Dennis W Dickson; Mei Zhen; David Ron; Gerold Schmitt-Ulms; Paul E Fraser; Neil A Shneider; Christine Holt; Michele Vendruscolo; Clemens F Kaminski; Peter St George-Hyslop
Journal:  Neuron       Date:  2015-10-29       Impact factor: 17.173

10.  Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic.

Authors:  Youn-Bok Lee; Han-Jou Chen; João N Peres; Jorge Gomez-Deza; Jan Attig; Maja Stalekar; Claire Troakes; Agnes L Nishimura; Emma L Scotter; Caroline Vance; Yoshitsugu Adachi; Valentina Sardone; Jack W Miller; Bradley N Smith; Jean-Marc Gallo; Jernej Ule; Frank Hirth; Boris Rogelj; Corinne Houart; Christopher E Shaw
Journal:  Cell Rep       Date:  2013-11-27       Impact factor: 9.423

View more
  19 in total

1.  Co-occurring medical conditions among individuals with ASD-associated disruptive mutations.

Authors:  Evangeline C Kurtz-Nelson; Jennifer S Beighley; Caitlin M Hudac; Jennifer Gerdts; Arianne S Wallace; Kendra Hoekzema; Evan E Eichler; Raphael A Bernier
Journal:  Child Health Care       Date:  2020-03-17

2.  A Mutation in Hnrnph1 That Decreases Methamphetamine-Induced Reinforcement, Reward, and Dopamine Release and Increases Synaptosomal hnRNP H and Mitochondrial Proteins.

Authors:  Qiu T Ruan; Neema Yazdani; Benjamin C Blum; Jacob A Beierle; Weiwei Lin; Michal A Coelho; Elissa K Fultz; Aidan F Healy; John R Shahin; Amarpreet K Kandola; Kimberly P Luttik; Karen Zheng; Nathaniel J Smith; Justin Cheung; Farzad Mortazavi; Daniel J Apicco; Durairaj Ragu Varman; Sammanda Ramamoorthy; Peter E A Ash; Douglas L Rosene; Andrew Emili; Benjamin Wolozin; Karen K Szumlinski; Camron D Bryant
Journal:  J Neurosci       Date:  2019-11-08       Impact factor: 6.167

3.  HNRNPR Variants that Impair Homeobox Gene Expression Drive Developmental Disorders in Humans.

Authors:  Floor A Duijkers; Andrew McDonald; Georges E Janssens; Marco Lezzerini; Aldo Jongejan; Silvana van Koningsbruggen; Wendela G Leeuwenburgh-Pronk; Marcin W Wlodarski; Sébastien Moutton; Frédéric Tran-Mau-Them; Christel Thauvin-Robinet; Laurence Faivre; Kristin G Monaghan; Thomas Smol; Odile Boute-Benejean; Roger L Ladda; Susan L Sell; Ange-Line Bruel; Riekelt H Houtkooper; Alyson W MacInnes
Journal:  Am J Hum Genet       Date:  2019-05-09       Impact factor: 11.025

Review 4.  Rett Syndrome Spectrum in Monogenic Developmental-Epileptic Encephalopathies and Epilepsies: A Review.

Authors:  Carlotta Spagnoli; Carlo Fusco; Francesco Pisani
Journal:  Genes (Basel)       Date:  2021-07-28       Impact factor: 4.096

5.  HNRNPH1 destabilizes the G-quadruplex structures formed by G-rich RNA sequences that regulate the alternative splicing of an oncogenic fusion transcript.

Authors:  Tam Vo; Tayvia Brownmiller; Katherine Hall; Tamara L Jones; Sulbha Choudhari; Ioannis Grammatikakis; Katelyn R Ludwig; Natasha J Caplen
Journal:  Nucleic Acids Res       Date:  2022-06-24       Impact factor: 19.160

6.  Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation.

Authors:  Qiu T Ruan; Neema Yazdani; Jacob A Beierle; Kathryn M Hixson; Kristen E Hokenson; Daniel J Apicco; Kimberly P Luttik; Karen Zheng; Brandon F Maziuk; Peter E A Ash; Karen K Szumlinski; Shelley J Russek; Benjamin Wolozin; Camron D Bryant
Journal:  Neurosci Lett       Date:  2018-07-09       Impact factor: 3.046

7.  Developmental epileptic encephalopathy with hypomyelination and brain atrophy associated with PTPN23 variants affecting the assembly of UsnRNPs.

Authors:  Robert Smigiel; Gerd Landsberg; Maximilian Schilling; Małgorzata Rydzanicz; Agnieszka Pollak; Anna Walczak; Anna Stodolak; Piotr Stawinski; Hanna Mierzewska; Maria M Sasiadek; Oliver J Gruss; Rafal Ploski
Journal:  Eur J Hum Genet       Date:  2018-06-13       Impact factor: 4.246

8.  Control of CNS functions by RNA-binding proteins in neurological diseases.

Authors:  Yijing Zhou; Fengping Dong; Yingwei Mao
Journal:  Curr Pharmacol Rep       Date:  2018-05-02

9.  Hnrnph1 is a novel regulator of alcohol reward.

Authors:  Elissa K Fultz; Michal A Coelho; Dylan Lieberman; C Leonardo Jimenez-Chavez; Camron D Bryant; Karen K Szumlinski
Journal:  Drug Alcohol Depend       Date:  2021-01-10       Impact factor: 4.492

Review 10.  Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases.

Authors:  Hong Joo Kim; J Paul Taylor
Journal:  Neuron       Date:  2017-10-11       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.